期刊文献+

IPC预防ICU重症患者深静脉血栓的成本效益分析 被引量:3

Cost benefit analysis of VTE prophylaxis with IPC in critically ill patients in ICU
下载PDF
导出
摘要 目的探讨使用间歇充气加压治疗(intermittent pneumatic compression,IPC)预防ICU重症患者发生静脉血栓栓塞症(venous thromboembolism,VTE)的成本效益。方法收集相关数据:未使用IPC预防的重症患者VTE的发生情况,使用IPC预防VTE的效果及成本,检查及治疗VTE的成本。分析IPC预防重症患者发生VTE的成本效益。结果在未使用IPC预防VTE的重症患者中,一旦发生VTE,人均增加的检查及治疗成本为$2754.6;在使用IPC的患者中,VTE的发生率显著降低,其发生VTE后人均增加的检查及治疗成本加上IPC使用成本合计为$1081.1;使用IPC预防VTE的人均效益为$1673.5。IPC预防VTE的效益成本比为3.9:1。结论使用IPC不但可以预防重症患者VTE的发生,还可以减少重症患者的住院费用。 Objective To determine the costs and savings of IPC for venous thromboembolism prophylaxis in critically ill patients in ICU. Methods VTE events after ICU admission in the absence of prophylaxis, efficacy of prophylaxis and costs of prophylaxis with IPC had been obtained and the cost benefit were analyzed for VTE prophylaxis with IPC. Results In the absence of prophylaxis, the increased cost of investigating and treating VTE was 2754. 6 for per critically ill patient. The cost of IPC and the increased cost of investigating and treating the reduced numbers of VTE was 1081.1 for per critically ill patient who was re- ceived VTE prophylaxis with IPC. This corresponded to a saving of 1673.5 for per critically ill patient. The benefit-cost ratio was 3.9 : 1. Results VTE prophylaxis with IPC in critically ill patients in ICU might not only prevented VTE, but also saved money.
作者 曾薇 张川
出处 《四川医学》 CAS 2013年第10期1479-1481,共3页 Sichuan Medical Journal
基金 四川省卫生厅课题(项目编号:080045)
关键词 重症患者 静脉血栓 预防 间歇充气加压 治疗 成本效益 critically ill patient venous thromboembolism prophylaxis IPC cost-benefit
  • 相关文献

参考文献6

  • 1Geerts WH, Bergqvist D, Pineo GF,et al. Prevention of venous throm- boembolism: American college of chest physicians evidence-based clinical practice guidelines [ J ]. Chest,2008,133 (6) : S381 - 453.
  • 2曾薇,张川,郑碧霞,李晓玉,姜远普,江利东,李孝锦,程金川.深静脉血栓对重症监护室患者的影响[J].中国医药,2012,7(10):1280-1281. 被引量:4
  • 3Ginzburg E, Cohn SM, Lopez J, et al. Randomized clinical trial of in- termittent pneumatic compression and low molecular weight heparin in trauma[J]. Br J, 2003,90:1338 - 1344.
  • 4Kurtoglu M, Yanar H, Bilsel Y, et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic com- pression devices versus low molecular weight heparin [ J ]. World J Surg,2004,28 : 807 - 811.
  • 5曾薇,张川,郑碧霞,程金川,马红原,李晓玉,姜远普,江利东.间歇充气加压治疗对GICU患者下肢深静脉血栓的预防作用[J].四川医学,2010,31(11):1576-1579. 被引量:8
  • 6Nicolaides A, Goldhaber S Z. Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery [ J ]. International Angiology ,2008,27 (6) :500 - 506.

二级参考文献11

  • 1Donald G,Maclell AN.Mechanical compression in the prophylaxis of venous thromboembolism[J].ANZ J Surg,2007,77(6):418-423.
  • 2Geerts WH,Bergqvist D,Pineo GF,et al.Prevention of venous thromboembolism:American College of Chest Physicians evidence-based clinical practice guidelines,8 th ed[J].Chest,2008,133(suppl6):381-453.
  • 3Thomas G,Delouhtry MD.Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants[J].Crit Care Clin,2005,21(3):497-512.
  • 4Jana Urbankova,Rene Quiroz.Intermittent pneumatic compression and deep vein thrombosis prevention.A meta-analysis in postoperative patients[J].Thromb Haemost,2005,94(6):1181-1185.
  • 5Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism : American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest ,2008,133 (6 Suppl) :381S-453S.
  • 6Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society ofCardiology (ESC). Eur Heart J,2008,29(18) :2276-2315.
  • 7Crowther MA, Cook DJ. Thromboprophylaxis in medical-surgical critically ill patients. Curr Opin Crit Care ,2008,14(5 ) :520-523.
  • 8贾小翠.“阳和汤”加减方治疗肾病综合征下肢深静脉血栓形成的疗效观察[J].中国医药,2008,3(7):425-426. 被引量:2
  • 9马晓春.ICU病人深静脉血栓形成预防指南[J].中国实用外科杂志,2009(10):793-797. 被引量:71
  • 10李丽华,张遥,赵喜荣.骨科手术后深静脉血栓形成的预防和治疗进展[J].实用药物与临床,2010,13(5):376-378. 被引量:21

共引文献9

同被引文献25

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部